Flow Traders U.S.’s VanEck Biotech ETF BBH Stock Holding History

Flow Traders U.S.’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,300	Closed	-$204K	–	931
2024 Q4	$204K	Buy	+1,300	New	+$219K	0.01%	875
2023 Q4	–	Sell	-1,794	Closed	-$279K	–	818
2023 Q3	$279K	Buy	+1,794	New	+$287K	0.01%	628
2021 Q4	–	Sell	-11,001	Closed	-$2.22M	–	756
2021 Q3	$2.22M	Buy	11,001 +2,733	+33%	+$574K	0.09%	242
2021 Q2	$1.67M	Buy	+8,268	New	+$1.54M	0.08%	275
2020 Q4	–	Sell	-5,835	Closed	-$946K	–	594
2020 Q3	$946K	Buy	+5,835	New	+$949K	0.07%	233
2017 Q1	–	Sell	-200	Closed	-$22K	–	307
2016 Q4	$22K	Buy	+200	New	+$21.8K	﹤0.01%	385

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Flow Traders U.S.'s BBH Position: Q1 2025 in Review

Flow Traders U.S. sold out of VanEck Biotech ETF (BBH) in Q1 2025, closing a stake of 1,300 shares — an estimated $204K sold.

Flow Traders U.S. first reported a position in BBH in Q4 2016 and held it in 6 quarters. The position peaked at $2.22M in Q3 2021. 104 funds tracked by Wall St. Rank hold BBH as of Q1 2025.

Flow Traders U.S. reported no remaining VanEck Biotech ETF position as of Q1 2025 after selling out during the quarter.
Flow Traders U.S. sold 1,300 VanEck Biotech ETF shares in Q1 2025, an estimated $204K.
Flow Traders U.S. first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 6 quarters.
Flow Traders U.S.'s VanEck Biotech ETF position peaked at $2.22M in Q3 2021.
104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2025.

Based on Flow Traders U.S.'s 13F filing for Q1 2025, filed 14 May 2025.